Zhong Lun advised LaNova Medicines in Completing its CNY 300 Million Series C1 Financing and Entering into Strategic Collaboration with Sino Biopharm. LaNova Medicines Technology (Shanghai)...
You must be a Standard 1 Year member to access this content.
O’Melveny & Myers represented Nkarta, Inc. in the offering, and Shearman & Sterling represented the underwriters. Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural...
You must be a Standard 1 Year member to access this content.
Shearman & Sterling represented Cowen and Company as sales agent in the transaction. Nkarta announced a U.S. at-the-market equity offering program to offer and sell common stock,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Amgen in the offerings, while Shearman & Sterling represented represented the underwriters. Amgen Inc. executed a senior unsecured notes offerings consisting of US$1,250,000,000 4.050%...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Inspire in the offering, while Shearman & Sterling advised Goldman Sachs, as sole book-running manager. Inspire Medical Systems, Inc. (NYSE: INSP) executd an...
You must be a Standard 1 Year member to access this content.
O’Melveny & Myers represented Nkarta, while Shearman & Sterling represented Cowen and Company, LLC, SVB Securities LLC and Evercore Group L.L.C., as representatives of the underwriters,...
You must be a Standard 1 Year member to access this content.
Shearman & Sterling represented AEye in the transaction. AEye, Inc. announced a $125 million equity line common stock purchase agreement with Tumim Stone Capital LLC (Tumim...
You must be a Standard 1 Year member to access this content.
Shearman & Sterling represented Aemetis in the transaction. Aemetis announced the commencement of its $300 million At-The-Market equity program. Aemetis is a renewable natural gas, renewable...
You must be a Standard 1 Year member to access this content.
Shearman & Sterling represented the joint book-running managers and representatives of the underwriters in the offering. Amgen’s registered $5 billion notes offering, consisting of 1.650 percent...
You must be a Standard 1 Year member to access this content.
Sullivan & Cromwell and De Brauw Blackstone Westbroek advised Ermenegildo Zegna Group, while Chiomenti and Kirkland & Ellis advised Investindustrial Acquisition Corp. on the transaction. Shearman...
You must be a Standard 1 Year member to access this content.
